Top Markets
Coin of the day
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Rangering i aksjer #93
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and... Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Aksjekurs
$137.21
Markedsverdi
$170.34B
Endring (1 dag)
-2.76%
Endring (1 år)
28.14%
Land
US
Handel Gilead Sciences, Inc. (GILD)

Kategori

Antall utestående aksjer for Gilead Sciences, Inc. (GILD)
Antall utestående aksjer per December 2025: 1.24B
Ifølge Gilead Sciences, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 1.24B. Ved slutten av December 2024 hadde selskapet 1.25B utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Gilead Sciences, Inc. (GILD) fra 2000 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 1.24B -0.16%
2025 1.24B -0.24%
2024 1.25B -0.08%
2023 1.25B -0.56%
2022 1.26B -0.08%
2021 1.26B -0.08%
2020 1.26B -1.02%
2019 1.27B -2.16%
2018 1.30B -0.69%
2017 1.31B -2.39%
2016 1.34B -8.54%
2015 1.46B -3.81%
2014 1.52B -0.43%
2013 1.53B 0.92%
2012 1.51B -2.27%
2011 1.55B -9.48%
2010 1.71B -5.37%
2009 1.81B -1.75%
2008 1.84B -0.91%
2007 1.86B 1.19%
2006 1.84B 1.05%
2005 1.82B 5.17%
2004 1.73B 7.41%
2003 1.61B 2.84%
2002 1.56B 2.78%
2001 1.52B 4.47%
2000 1.46B 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
898.00M -27.70%
US
3.10B 149.60%
GB
2.43B 95.54%
US
1.78B 43.35%
US
1.91B 54.03%
CH